South Africa Ventricular Assist Device Market By Application Type, By Type, and By Design – Opportunities & Forecast, 2018-2025
South Africa Ventricular Assist Device Market, By Application Type (Bridge-to-transplant (BTT) Therapy, Destination Therapy and Bridge-to-recovery (BTR) Therapy), By Type (Left Ventricular, Right Ventricular and Biventricular Assist Device), and By Design (Implantable Device and Transcutaneous Device) – Opportunities & Forecast, 2018-2025
The South Africa Ventricular Assist Device Market was valued at USD XX million in 2017, and is projected to reach USD XX million by 2025, growing at a healthy CAGR 11.0 % during 2018-2025.
Figure 1: South Africa Ventricular Assist Device Market Revenue, 2018-2025 (USD Million)
Source: GMI Research
Major Factors such as growing cardiac patient’s pool with heart failures, paradigm shift to minimally invasive surgeries from traditional surgeries, high prevalence of cardiac diseases and shortage of heart donors are driving the growth of the market.
Bridge-to-transplant (BTT) Therapy segment held the biggest revenue share in 2018 and is expected to dominate the market during the forecast period but the fastest growth rate is predicted to be exhibited by Bridge-to-recovery (BTR) Therapy segment in upcoming few years due to the growing heart donors in the country. Additionally, development of medical devices to treat various type of cardiac diseases is likely to drive the growth of ventricular assist device market in the forecasted period.
Based on Product Type, Left Ventricular Assist Device segment is to dominate the market during 2018-2025
Left Ventricular Assist Device segment is expected to hold maximum share in the market during the forecast period due to increase in the number of cases related to ventricular septum failure. In addition, rising adoption of minimally invasive procedure In LVD implantation will also spur the market growth during the forecast period
Advanced healthcare services and carrying out innovation are the focussed area by key manufacturer to maintain their leadership in South Africa Ventricular Assist Device market.
Various notable players operating in South Africa Ventricular Assist Device Market include Jarvik Heart, Inc., Reliant Heart, Inc., Abbott Healthcare, Berlin Heart GmbH, Cardiac Assist, Inc. (LivaNova), HeartWare International, Inc., Syncardia System, Inc., Sun Medical Technology Research Corp., Thoratec Corporation, and Abiomed Inc. among others
The South Africa Ventricular Assist Device market has been segmented on the basis of Application, Type and Design Segmentation. Based on Application type, the market comprises of Bridge-to-transplant (BTT) Therapy, Destination Therapy and Bridge-to-recovery (BTR) Therapy. The Product type includes Left Ventricular, Right Ventricular and Biventricular Assist Device.
The research report “South Africa Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, South Africa, based on application type, product type and design type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.
Key questions answered in this research report:
1. At what pace is the Ventricular Assist Device Market growing in the region? What will be the growth trend in future?
2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3. What are the various application areas and how they are poised to grow?
Why GMI Research
